Healthcare Professional Resources
LANTUS® Site References
- LANTUS® Prescribing Information.
- Lepore M, Pampanelli S, Fanelli C, et al. Diabetes. 2000;49:2142-2148.
- Yki-Järniven H, Ziemen M, Dressler A. Diabetes Care. 2000;23(8):1130-1136.
- Data on file, sanofi-aventis U.S. LLC (Diabetes Monitor).
- Riddle MC, Rosenstock J, Gerich J, on behalf of the Insulin Glargine 4002
Study Investigators. Diabetes Care. 2003;26:3080-3086.
- Data on file, sanofi-aventis U.S. LLC (CSR HOE901/4002).
- Schreiber SA, Ferlinz K, Haak T. The long-term efficacy of insulin glargine
plus oral antidiabetic agents in a 32-month observational study of everyday clinical
practice. Diabetes Technology & Therapeutics 2008;10:121-127.
- Janka HU, Plewe G, Riddle MC, et al. Diabetes Care. 2005;28:254-259.
- Data on file, sanofi-aventis U.S. LLC (CSR HOE901/4027).
- Hammer H, Klinge A. Int J Clin Pract. 2007;61(12):2009-2018.
- Davies M, Storms F, Shutler S, et al. Diabetes Care. 2005;28:1282-1288.
- McKeage K, Goa KL. Drugs. 2001;61:1599-1624.
- Gerstein HC, Yale JF, Harris SB, et al. Diabet Med. 2006;23:736-742.
- Edelman SV, Morello CM. South Med J. 2005;98:363-371.
- Leahy JL. In: Leahy JL, Cefalu WT, eds. Insulin Therapy. New York,
NY: Marcel Dekker Inc; 2002:87-112.
- AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. Endocr
Pract. 2007;13(suppl 1):4-68.
- Levemir Prescribing Information.
- Clement S, Braithwaite SS, Magee MF, et al. Diabetes Care. 2004;27:553-591.
- Skyler JS. In: DeFronzo RA, ed. Current Therapy of Diabetes Mellitus.
St Louis, Mo: Mosby-Year Book; 1998:108-116.
- Fonseca V. Endocr Pract. 2006;12(suppl 3):108-111.
- Galloway JA, Chance RE. Horm Metab Res. 1994;26:591-598.
- Porcellati F, Rossetti P, Busciantella NR, et al. Diabetes Care.
2007;30(10):2447-2452.
- Bode BW, Braithwaite SS, Steed RD, Davidson PC. Endocr Pract. 2004;10(suppl
2):71-80.
- Clarke A, Spollett G. Expert Opinion Drug Deliv. 2007;4:165-174.
- Data on file, sanofi-aventis U.S. LLC.
- Data on file, sanofi-aventis U.S. LLC.